AM 580 is a selective retinoic acid analog, which is useful in vitro as a RARα agonist. Studies indicate that RARα increases the signaling of the RARα receptor to prevent intracellular and extracellular amyloid-β accumulation. In addition, this receptor increases the expression of disintegrin and metalloprotease. Since amyloid-β accumulation is a major finding in Alzheimer's disease (AD), AM 580 can be used to study this disease in vitro. AM 580 also induces the functions of IL-4, IL-5 and IL-13 and suppresses the production of IL-12 and IFNγ. Alternate studies suggest that AM 580 inhibits tumor proliferation by reducing the level of RARγ and activates RAR β.
1. Kagechika, H., et al., 1988. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. Journal of medicinal chemistry. 31(11): 2182-92. PMID: 3184125
2. Charton, Julie., et al., 2009. Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives. Bioorganic & medicinal chemistry letters. 19(2): 489-92. PMID: 19058965
3. Jarvis, C I., et al., 2010. Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β. The European journal of neuroscience. 32(8): 1246-55. PMID: 20950278
See how others have used AM 580. Click on the entry to view the PubMed entry .
PMID: # 24264050 Xu, S. et al. 2014. Am. J. Physiol. Gastrointest. Liver Physiol. 306: G154-62.
PMID: # 24454758 Araoka, T. et al. 2014. PLoS ONE. 9: e84881.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.